Rural Veteran and Care Partner Walking Program
Remotely Improving Physical Activity in Rural Veterans With Cognitive Impairment and Care Partner Dyads
The purpose of this study is to determine the practicality/feasibility of a virtual physical activity intervention to improve daily steps for Veterans with mild cognitive impairment and their care partners living in rural areas.
Participation includes:
- Complete a 6-week walking program
- Complete 2 testing visits (1 before and 1 after the 6-week walking program) consisting of various surveys and questionnaires
- Complete a semi-structured interview on feasibility and feedback of the intervention
- Potentially serve on an advisory board with the research team to assist with implementing the walking program adaptations
研究概览
地位
地位
干预/治疗
干预/治疗
研究类型
研究类型
注册 (估计的)
注册
阶段
阶段
- 不适用
联系人和位置
学习联系方式
学习联系方式
- 姓名:Rashelle Hoffman, PT, DPT, PhD
- 电话号码:402-280-5691
- 邮箱:rashellehoffman@creighton.edu
学习地点
-
-
Nebraska
-
Omaha、Nebraska、美国、68178
- 招聘中
- Creighton University
-
接触:
- Rashelle Hoffman, PT, DPT, PhD
- 电话号码:402-280-5691
- 邮箱:rashellehoffman@creighton.edu
-
-
参与标准
资格标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria for Veterans:
- 60-95 years of age
- Mild cognitive impairment as staged by Clinical Dementia Rating (CDR, a gold standard cognitive outcome in ADRD clinical research) score of 0.5 or equivalent
- Characterized as underactive by the Telephone Assessment of Physical Activity (TAPA)
- Have a care partner willing to participate in physical activity and assist the participant
- Own a smartphone or tablet and willing to download a fitness tracker application
- Live in a rural area according to the VA Office of Rural Health rurality calculator
Inclusion Criteria for Veterans & Care Providers:
- No self-reported falls in the last year
- Able to walk across a room in the home with no assistive device(s)
- Stable doses of medication over the previous 30 days
- Pass the Physical Activity Readiness Questionnaire+ (answering "no" to questions are pages 1-3)
- Interaction as a dyad (Veteran and care partner) at least on a weekly basis
Inclusion Criteria for Veterans & Care Providers:
- 19 years of age or older
- No cognitive impairment as indicated by a score of < 1 on the AD8 Dementia Screening Interview
Exclusion Criteria for Veterans & Care Providers:
- Neurodegenerative or acute neurological diagnoses (e.g., Parkinson's disease, stroke, traumatic brain injury)
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
手臂数量
武器和干预
参与者组/臂参与者组/臂 |
干预/治疗干预/治疗 |
|---|---|
|
实验性的:Field Testing Group
|
Six dyads (n=12) will complete TPAB field testing and will undergo testing at baseline and post-intervention. Consent, baseline testing, intervention delivery, and post-testing will be conducted virtually via Microsoft Teams and data recorded in VA REDCap. Testing sessions will not be recorded, with the exception of semi-structured interviews during post-testing. The testing procedures will take approximately 2 hours to complete at each testing time point. The TPAB intervention will involve weekly 30-minute sessions with study personnel for 6 weeks. Due to the 7-day activity monitor data collection prior to and following the 6-week TPAB intervention, participants will be enrolled in the study for approximately 8 weeks. Three dyads will be asked to join the advisory board with the research team to assist with implementing the walking program adaptations based on the collective feedback across the 16 dyads. |
研究衡量的是什么?
主要结果指标
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Weekly Session Attendance
大体时间:From enrollment to end of the 6-week intervention
|
The total number of sessions attended by dyads will be reported as a percentage of the 6 weekly sessions. Ranges of attendance could be 0% (not attending any sessions) to 100% attending all session. Attendance will be used to evaluate participant engagement and practicality of implementation. |
From enrollment to end of the 6-week intervention
|
|
Study Retention
大体时间:From enrollment to end of intervention at 8 weeks
|
Defined as continued participation through the study completion. Calculated using withdrawal and completion records. Higher retention (such as 100% retention indicating all dyads that enrolled in the study, completed the study) supports intervention feasibility. |
From enrollment to end of intervention at 8 weeks
|
|
Intrinsic Motivation Inventory (IMI)
大体时间:Post-intervention (week 8)
|
Evaluates participant interest, enjoyment, perceived value, and engagement with the intervention. The IMI is comprised of 7 statements related to interest/enjoyment that the participant indicates how true the statement is to them regarding their experience participating in the intervention. Each statement is scored on a 1-7 scale and an average is computed across all the questions to determine the IMI score. Higher scores indicate greater intervention acceptability. |
Post-intervention (week 8)
|
|
Number of participants with study-related adverse events
大体时间:From enrollment to end of intervention at 8 weeks
|
Includes falls, injuries, medical issues, skin irritation, or other unintended consequences. Used to evaluate intervention safety. |
From enrollment to end of intervention at 8 weeks
|
|
Average Daily Stepping
大体时间:Pre (before starting the 6-week walking program) and Post Intervention (following completion of the 6-week walking program)
|
Objective measure of physical activity captured through Fitbit devices. Average daily step counts are computed in the Fitbit application and will be recorded for each day and averaged over the 7-day monitoring period before and after the intervention provide proof-of-concept evidence of behavior change. |
Pre (before starting the 6-week walking program) and Post Intervention (following completion of the 6-week walking program)
|
|
Qualitative Intervention Feasibility Outcomes
大体时间:Post-intervention (for feedback)
|
Interviews evaluating demand, implementation, practicality, acceptability, adaptation, and integration. Findings will guide refinement of the intervention for future trials. |
Post-intervention (for feedback)
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
学习开始
初级完成 (估计的)
初级完成
研究完成 (估计的)
研究完成
研究注册日期
首次提交
首次提交
首先提交符合 QC 标准的
首先提交符合 QC 标准的
首次发布 (实际的)
首次发布
研究记录更新
最后更新发布 (实际的)
最后更新发布
上次提交的符合 QC 标准的更新
上次提交的符合 QC 标准的更新
最后验证
最后验证
更多信息
与本研究相关的术语
其他研究编号
其他研究编号
- Creighton IRB: 2005570
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.